NN9924-4635
This trial is a 68 week double blind trial evaluating 3 doses of semaglutide in people with type 2 diabetes.
This trial is a 68 week double blind trial evaluating 3 doses of semaglutide in people with type 2 diabetes.
Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects with Type 2 Diabetes Mellitus
Study of Ricolinostat in Patients With Diabetic Neuropathy Pain
Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Pediatric Subjects
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
A Study of LY900014 in participants with Type 2 Diabetes using Continuous Glucose Monitoring
This trial compares the efficacy and safety of tirzepatide once weekly at either 5 mg, 10 mg, 15 mg dose to 3 times a day Lispro in patients with type 2 diabetes on glargine.
Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab, in Children and Adolescents, Newly Diagnosed Type 1 Diabetes
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events and Efficacy Measures in Hypogonadal Men
Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.
The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.
Evaluate the Safety of Ly3209590 in Patients with type 1 diabetes being treated with multiple daily injection therapy.
Fill out the form below an we will let you know when a study becomes available that you may be interested in: